<- Go Home

Tottenham Acquisition I Limited

As of December 30, 2020, was acquired by Clene Nanomedicine Inc., in a reverse merger transaction.

Market Cap

$14.7M

Volume

29.5K

Cash and Equivalents

$440.1K

EBITDA

N/A

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

N/A

Profit Margin

N/A

52 Week High

$17.50

52 Week Low

$6.40

Dividend

N/A

Price / Book Value

2.94

Price / Earnings

-16.02

Price / Tangible Book Value

2.94

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$1.1M

Return on Equity

9.18%

Return on Assets

-1.81

Cash and Short Term Investments

$440.1K

Debt

$3.2M

Equity

$5.0M

Revenue

N/A

Unlevered FCF

-$528.6K

Sector

Capital Markets

Category

N/A

Company Stock Pitches